TECOGEN INC. — Director's Dealing 2022

Mar 16, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TECOGEN INC. (TGEN)
CIK: 0001537435
Period of Report: 2022-03-09

Reporting Person: Rangesh Abinand (Director, Chief Financial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$3.91	2026-12-12	Common Stock (10000.0)		Direct
Stock Option (Right to Buy)	$0.71	2030-07-09	Common Stock (50000.0)		Direct
Stock Option (Right to Buy)	$1.1	2031-01-21	Common Stock (70000.0)		Direct

Footnotes

F1: Vests 25% per year

F2: Vests 50% upon achievement of Adjusted EBITDA goal in two consecutive quarters, and 50% upon achievement of Adjusted EBITDA goal in four consecutive quarters

F3: Vests 50% per year